Severe hypocalcemia in dialysis-dependent elderly linked to Denosumab. | |
A recent study published in the Journal of the American Medical Association has found that denosumab, a drug used to treat osteoporosis, is linked to a higher risk of severe or very severe hypocalcemia in female patients aged 65 or older who are dependent on dialysis. The research was led by Steven T. Bird, Ph.D., Pharm.D., from the U.S. Food and Drug Administration, and his team. They conducted a retrospective cohort study comparing the risk of severe hypocalcemia in patients treated with denosumab and those treated with oral bisphosphonates. Severe hypocalcemia was defined as total albumin-corrected serum calcium less than 7.5 mg/dL or a primary hospital or emergency department diagnosis of hypocalcemia. Very severe hypocalcemia was defined as serum calcium less than 6.5 mg/dL. For more details please visit our website - https://www.medhealthinsight.com/new-soundboard-review-pricing-is-not-always-the-only-criteria-2-11/ ![]() | |
Related Link: Click here to visit item owner's website (1 hit) | |
Target State: New York Target City : New York City Last Update : Sep 01, 2025 2:23 AM Number of Views: 25 | Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |